The GINDEX® Growth Infusion International Index (GNDXI)

The GINDEX® Growth Infusion International Index (GNDXI) is an equally weighted index measuring the performance of international companies that have previously acquired 100% Interest in a firm that has gone public through IPO, Direct Listing, and Spin-off in all world regions, except the United States (“IPO M&A”). The index utilizes a 10% cap on all constituents and is reconstituted and adjusted quarterly.

Key Features:

  • International IPO Acquirer Focus: Targets established international (ex-U.S.) companies acquiring firms shortly after their public market debut globally.

  • Global Growth Infusion: Extends the "growth infusion" strategy beyond the U.S., capturing potential benefits from integrating global innovation.

  • Equal Weighting & Diversification: Provides balanced exposure across international acquirers and quarterly rebalancing.

  • Broad Geographic Coverage: Includes companies from Europe, Asia-Pacific, Canada, and other ex-U.S. regions.

Capturing Global Growth Through International IPO Acquisitions

A Global Strategy for Innovation

The rationale for acquiring newly public companies to access innovation and growth potential is a global phenomenon. The GINDEX® Growth Infusion International Index identifies established international leaders that employ this strategy. Prominent examples include European industrial and tech giants like Siemens, SAP, and Dassault Systemes, healthcare leaders such as Roche and AstraZeneca, and Asian powerhouses like Alibaba and Mitsubishi UFJ Financial Group.

Diverse International Acquirers

The index showcases the geographic and sector diversity of international companies leveraging IPO M&A. European representation includes firms like BAE Systems (UK Defence), Zurich Insurance Group (Swiss Insurance), and EssilorLuxottica (French/Italian Eyewear). From Asia-Pacific, examples include Naver (South Korean Internet), Sompo Holdings (Japanese Insurance), and Advantest (Japanese Semiconductor Equipment). The Americas (ex-U.S.) are represented by companies like Enbridge (Canadian Energy) and Constellation Software (Canadian Tech).

Together, the GINDEX® Growth Infusion U.S. and International Indexes offer investors distinct approaches to capturing potential long-term growth by focusing on established companies actively shaping their future through strategic acquisitions of newly public firms, both domestically and globally.

Contact info@ipox.com for licensing and sub-advisory opportunities.